The Food and Drug Administration (FDA) announced Friday that it has issued emergency use authorization (EUA) for Eli Lilly's new monoclonal antibody treatment. Clinical trials have shown the treatment ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback